BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23160528)

  • 1. Local autoantigen expression as essential gatekeeper of memory T-cell recruitment to islet grafts in diabetic hosts.
    Alkemade GM; Clemente-Casares X; Yu Z; Xu BY; Wang J; Tsai S; Wright JR; Roep BO; Santamaria P
    Diabetes; 2013 Mar; 62(3):905-11. PubMed ID: 23160528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation.
    Wang J; Tsai S; Shameli A; Yamanouchi J; Alkemade G; Santamaria P
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9317-22. PubMed ID: 20439719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantigen recognition is required for recruitment of IGRP(206-214)-autoreactive CD8+ T cells but is dispensable for tolerance.
    Wang J; Tsai S; Han B; Tailor P; Santamaria P
    J Immunol; 2012 Sep; 189(6):2975-84. PubMed ID: 22908330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
    Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
    PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
    Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
    J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective prediction of spontaneous but not recurrent autoimmune diabetes in the non-obese diabetic mouse.
    Trudeau JD; Chandler T; Soukhatcheva G; Verchere CB; Tan R
    Diabetologia; 2007 May; 50(5):1015-23. PubMed ID: 17334749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
    Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
    J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach.
    Niens M; Grier AE; Marron M; Kay TW; Greiner DL; Serreze DV
    Diabetes; 2011 Apr; 60(4):1229-36. PubMed ID: 21346176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.
    Vincent BG; Young EF; Buntzman AS; Stevens R; Kepler TB; Tisch RM; Frelinger JA; Hess PR
    J Immunol; 2010 Apr; 184(8):4196-204. PubMed ID: 20220085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.
    Lieberman SM; Evans AM; Han B; Takaki T; Vinnitskaya Y; Caldwell JA; Serreze DV; Shabanowitz J; Hunt DF; Nathenson SG; Santamaria P; DiLorenzo TP
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8384-8. PubMed ID: 12815107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
    Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
    J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
    Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
    J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas.
    Dogra RS; Vaidyanathan P; Prabakar KR; Marshall KE; Hutton JC; Pugliese A
    Diabetologia; 2006 May; 49(5):953-7. PubMed ID: 16520917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
    Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
    J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.